HSTIX Performance — Stock Index Fund
Data updated: 2026-08-04
HSTIX returned +9.93% year to date and +21.72% over one year to Jun 2026. Annualised returns are +20.05% over 3 years and +12.87% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $173, against $157 for the category, and to $122 over one year, against $118. Volatility over the past three years was 13.05% a year. In the 12 months to Jun 2026 the fund lost a net $5.0M, and assets reached $323.86M.
HSTIX Growth of $100
What $100 invested in Stock Index Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | HSTIX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $122 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $173 | $157 |
| 5 years (Jul 2021 – Jun 2026) | $183 | $161 |
| Since data start (Jul 2019 – Jun 2026) | $274 | $229 |
HSTIX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.93% |
| 1 year | +21.72% |
| 3 years (annualised) | +20.05% |
| 5 years (annualised) | +12.87% |
HSTIX Annual Returns
Calendar-year total returns of Stock Index Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +9.93% |
| 2025 | +17.35% |
| 2024 | +24.40% |
| 2023 | +25.73% |
| 2022 | −18.50% |
| 2021 | +28.10% |
| 2020 | +17.80% |
| 2019 (Jul–Dec) | +10.59% |
HSTIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.4% | −0.8% | −5.0% | +10.4% | +5.2% | −1.0% | — | — | — | — | — | — |
| 2025 | +2.8% | −1.4% | −5.7% | −0.7% | +6.2% | +5.1% | +2.2% | +2.0% | +3.6% | +2.3% | +0.2% | 0.0% |
| 2024 | +1.7% | +5.3% | +3.2% | −4.1% | +4.9% | +3.5% | +1.2% | +2.4% | +2.1% | −0.9% | +5.8% | −2.4% |
| 2023 | +6.2% | −2.5% | +3.6% | +1.5% | +0.4% | +6.6% | +3.2% | −1.6% | −4.8% | −2.2% | +9.1% | +4.5% |
| 2022 | −5.2% | −3.0% | +3.7% | −8.7% | +0.1% | −8.3% | +9.2% | −4.1% | −9.2% | +8.1% | +5.5% | −5.8% |
| 2021 | −1.0% | +2.7% | +4.3% | +5.3% | +0.6% | +2.3% | +2.3% | +3.0% | −4.7% | +7.0% | −0.7% | +4.5% |
| 2020 | −0.1% | −8.3% | −12.4% | +12.8% | +4.7% | +1.9% | +5.6% | +7.1% | −3.8% | −2.7% | +10.9% | +3.8% |
| 2019 | — | — | — | — | — | — | +1.4% | −1.7% | +1.8% | +2.1% | +3.6% | +3.0% |
HSTIX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.05%
- 3-year Sharpe ratio: 1.19 (vs 4.5% risk-free rate)
- Best month: +10.43% (Apr 2026)
- Worst month: −5.66% (Mar 2025)
HSTIX Fund Flows
Monthly money in and out of Stock Index Fund, from SEC Form N-PORT.
- 12-month net flow: −$5.0M
- 12-month gross sales (incl. reinvestments): $34.1M
- Sales ÷ redemptions: 0.87×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $2.2M | $3.6M | −$1.4M |
| May 2026 | $5.2M | $3.2M | $2.1M |
| Apr 2026 | $3.9M | $3.5M | $381K |
| Mar 2026 | $2.5M | $3.1M | −$667K |
| Feb 2026 | $2.5M | $3.0M | −$558K |
| Jan 2026 | $2.0M | $4.8M | −$2.8M |
| Dec 2025 | $7.5M | $2.5M | $5.0M |
| Nov 2025 | $893K | $2.7M | −$1.8M |
| Oct 2025 | $1.5M | $3.2M | −$1.7M |
| Sep 2025 | $1.4M | $3.2M | −$1.8M |
| Aug 2025 | $1.8M | $3.5M | −$1.7M |
| Jul 2025 | $2.6M | $2.8M | −$176K |
HSTIX Assets Under Management
Net assets of Stock Index Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $323.86M |
| 2026-03-31 | $280.84M |
| 2025-12-31 | $297.91M |
| 2025-09-30 | $293.70M |
| 2025-06-30 | $275.42M |
| 2025-03-31 | $248.51M |
| 2024-12-31 | $261.40M |
| 2024-09-30 | $264.40M |
| 2024-06-30 | $249.98M |
| 2024-03-31 | $241.24M |
| 2023-12-31 | $225.39M |
| 2023-09-30 | $207.41M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.